Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

研究方向

Immunology/Inflammation 相关产品(4245)

  • GC18923 structure
    GC18923URB937
    CAS: 1357160-72-5
    纯度: >95.00% / >98.00%

    URB937是口服有效的、外周限制性的脂肪酸酰胺水解酶(FAAH)特异性抑制剂,IC 50 为26.8nM。

  • GC18936 structure
    GC18936A-83016F
    CAS: 142435-72-1

    An aurodox antibiotic

  • GC18955 structure
    GC18955Reveromycin C
    CAS: 144860-69-5

    A polyketide with antifungal activity

  • GC18964 structure
    GC18964Palitantin
    CAS: 15265-28-8

    A fungal metabolite

  • GC18978 structure
    GC18978Aspartocin D
    CAS: 1562369-96-3

    A lipopeptide antibiotic

  • GC18984 structure
    GC18984Saccharocarcin B
    CAS: 158475-33-3

    A macrocyclic lactone antibiotic

  • GC18988 structure
    GC18988ML RR-S2 CDA (ammonium salt)
    CAS: 1638750-96-5
    纯度: >98.00%

    An activator of STING

  • GC19001 structure
    GC19001Tetromycin B
    CAS: 180027-84-3

    A cysteine protease inhibitor

  • GC19002 structure
    GC19002Penigequinolone A
    CAS: 180045-91-4

    An alkaloid

  • GC19008 structure
    GC19008Leucomycin A5
    CAS: 18361-45-0

    A macrolide antibiotic

  • GC19043 structure
    GC19043Avacopan
    CAS: 1346623-17-3

    A C5a 1 receptor antagonist

  • GC19046 structure
    GC19046AX-024 hydrochloride
    CAS: 1704801-24-0
    纯度: >99.00%

    An inhibitor of the CD3ε-Nck interaction

  • GC19070 structure
    GC19070LMT-28
    CAS: 1239600-18-0
    纯度: >98.50% / >98.00% / >99.50%

    LMT-28 是一种具有口服活性的合成 IL-6 抑制剂,通过直接结合 gp130 发挥作用。

  • GC19113 structure
    GC19113CY-09
    CAS: 1073612-91-5
    纯度: >98.00%

    CY-09 是 NLRP3 炎性体的特异性抑制剂,直接靶向 NLRP3,对五种主要细胞色素 P450 酶中的每一种酶的 IC50 值为 18.9、8.18、>50、>50 和 26.0 uM。

  • GC19193 structure
    GC19193HTHQ
    CAS: 148081-72-5
    纯度: >99.50%

    An antioxidant

  • GC19201 structure
    GC19201INF39
    CAS: 866028-26-4
    纯度: >99.00%

    An NLRP3 inflammasome inhibitor

  • GC19245 structure
    GC19245PHYSALIEN
    CAS: 144-67-2
    纯度: >95.00%

    PHYSALIEN是一种脂溶性的类胡萝卜素类化合物。

  • GC19254 structure
    GC19254ML385
    CAS: 846557-71-9
    纯度: >98.00% / >99.50%

    ML385是一种特定的核因子红细胞2相关因子2(NRF2)抑制剂。

  • GC19357 structure
    GC19357TLR7-agonist-1
    CAS: 1642857-69-9
    纯度: >99.00%

    A TLR7 agonist

  • GC19377 structure
    GC19377Visomitin
    CAS: 934826-68-3
    纯度: >98.00% / >97.00%

    A mitochondrial antioxidant

  • GC19428 structure
    GC19428Angeli’s Salt
    CAS: 13826-64-7
    纯度: >99.00%

    A classical nitroxyl (NO-) donor

  • GC19432 structure
    GC19432BXL-628
    CAS: 199798-84-0

    A vitamin D 3 analog with diverse biological activities

  • GC19457 structure
    GC19457Trolox
    CAS: 53188-07-1
    纯度: >98.00%

    Vitamin E derivative with antioxidant properties

  • GC19496 structure
    GC19496AAPH
    CAS: 2997-92-4
    纯度: >99.00%

    A water-soluble azo compound used as a free radical generator